youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
A1RG34:BVMF
Argenx Se Bdr
R$162.13
0.00%
(0.00) 1D
Oct 16, 10:03:00 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
51.38B
Avg. vol.
59.00
Volume
0.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.89M
No. of employees
2K
Mkt. cap
51.38B
Avg. vol.
59.00
Volume
0.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Argenx stock: Goldman Sachs keeps EUR 959.00 target for Argenx stock
Investing.com
·
2 hours ago
argenx reports positive phase 3 results for myositis treatment
ad-hoc-news.de
·
7 hours ago
argenx sets October 22 results date for argenx stock
ad-hoc-news.de
·
9 hours ago
Argenx stock at EUR 732.70 ahead of the Xetra open today
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr